The objective was to determine the frequency of augmentation mammoplasty in female patients with systemic sclerosis (SSc).
Female patients with a clinical diagnosis of SSc were identified from the registry of the Johns Hopkins-University of Maryland Scleroderma Center, Washington D.C. Chapter of the Scleroderma Foundation, and files of practicing rheumatologists in the Baltimore-Washington metropolitan area.
A pretested questionnaire was mailed to all eligible cases.
Of 339 cases, 210 (62%) returned completed questionnaires.
Three cases reported augmentation mammoplasty with silicone gel-filled prosthesis : 2 (1%) prior to and 1 (0.5%) after physician-diagnosis of SSc.
The frequency of augmentation mammoplasty prior to physician-diagnosis of SSc of 9.5 per 1000 does not appear to differ from the expected frequency of 3.3-8.2 per 1000 derived from national population samples.
A well-designed case-control study with population-based controls and adequate statistical power is being conducted to examine this possible association.
Mots-clés Pascal : Chirurgie plastique, Glande mammaire, Prothèse, Sclérodermie, Systémique, Complication, Siloxane polymère, Homme, Femelle, Epidémiologie, Etats Unis, Amérique du Nord, Amérique, Peau pathologie, Tissu conjonctif pathologie, Maladie système, Maladie autoimmune, Immunopathologie
Mots-clés Pascal anglais : Plastic surgery, Mammary gland, Prosthesis, Scleroderma, Systemic, Complication, Siloxane polymer, Human, Female, Epidemiology, United States, North America, America, Skin disease, Connective tissue disease, Systemic disease, Autoimmune disease, Immunopathology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0241757
Code Inist : 002B07. Création : 09/06/1995.